Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor (Q58579391)
Jump to navigation
Jump to search
scientific article published on 09 October 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor |
scientific article published on 09 October 2018 |
Statements
Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor (English)
Lin Xihua
Tang Shengjie
Gui Weiwei
Erik Matro
Tao Tingting
Li Lin
Wu Fang
Zhou Jiaqiang
Zheng Fenping
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference